Sellma Therapeutics, Foreign Investors Net Buy 32,225 Shares... Stock Price Up 2.43%
Cellma Therapeutics has newly appeared among the top searched stocks.
As of 12:31 PM on the 12th, Cellma Therapeutics is trading at 7,580 KRW, up 2.43% from the previous day. This marks a 16.08% increase compared to March 2. Cellma Therapeutics is known as a distributor of gift certificate discounts and dental materials.
Today, foreigners have a tentative net purchase of 32,225 shares. Over the past five days, individual investors have net purchased 73,772 shares, while foreigners and institutions have net purchased 1,645 shares and 13,443 shares, respectively.
On March 11, Cellma Therapeutics became a market issue with the headline "Russia COVID-19 Vaccine Contract Manufacturing... Surges 18.16%".
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
